Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 11/20 | 1.00 |
| ▸ | NR1H2 | P55055 | 5/20 | 0.72 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.72 |
| ▸ | RORA | P35398 | 4/20 | 0.72 |
| ▸ | RORB | Q92753 | 4/20 | 0.72 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.72 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.72 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | RXRA | P19793 | 1/20 | 0.55 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.55 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.55 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.55 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.55 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.55 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.55 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.55 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14732108 | 0.85 | RORC (0.79) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL2938741 | 0.84 | RORC (0.77) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL14732110 | 0.84 | RORC (1.00) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL14747545 | 0.76 | RORC (0.68) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL18235558 | 0.73 | HSD11B1 (1.00) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL7867767 | 0.72 | NR1H3 (0.68) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL12334077 | 0.72 | RORC (0.81) | RORCNR1H2NR1I2RORARORB | |
| T091317 SCHEMBL457231 | 0.71 | RORC (1.00) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL16731518 | 0.70 | RORC (0.81) | RORCNR1H2NR1I2RORARORB | |
| SCHEMBL14732184 | 0.70 | RORC (0.77) | RORCNR1H2NR1I2RORARORB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180258133-A1 | MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA | ORPHAGEN PHARMACEUTICALS INC (US) | 2018-09-13 | — | — | US | disclosed |
| US-20170267712-A1 | MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA | ORPHAGEN PHARMACEUTICALS INC (US) | 2017-09-21 | — | — | US | disclosed |
| US-9657053-B2 | Modulators of retinoid-related orphan receptor gamma | Orphagen Pharmaceuticals (US) | 2017-05-23 | — | — | US | disclosed |
| US-20130150333-A1 | MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA | Orphagen Pharmaceuticals (US) | 2013-06-13 | — | — | US | disclosed |
| US-8389739-B1 | Modulators of retinoid-related orphan receptor gamma | Orphagen Pharmaceuticals (US) | 2013-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180258133-A1 | MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA | RORC, RORB, RORA | RORC 1/4885NR1H2 11/4885NR1I2 24/4885 |
| US-20130150333-A1 | MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA | RORC, RORB, RORA | RORC 1/4885NR1H2 11/4885NR1I2 24/4885 |
| US-20170267712-A1 | MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA | RORC, RORB, RORA | RORC 1/4885NR1H2 11/4885NR1I2 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.